Cargando…
Immunotherapy with Allergen Peptides
Specific allergen immunotherapy (SIT) is disease-modifying and efficacious. However, the use of whole allergen preparations is associated with frequent allergic adverse events during treatment. Many novel approaches are being designed to reduce the allergenicity of immunotherapy preparations whilst...
Autor principal: | Larché, Mark |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2873623/ https://www.ncbi.nlm.nih.gov/pubmed/20525144 http://dx.doi.org/10.1186/1710-1492-3-2-53 |
Ejemplares similares
-
Modulation of CRTh2 expression on allergen‐specific T cells following peptide immunotherapy
por: Rudulier, Christopher D., et al.
Publicado: (2019) -
Allergen Peptides, Recombinant Allergens and Hypoallergens for Allergen-Specific Immunotherapy
por: Marth, Katharina, et al.
Publicado: (2014) -
Allergen immunotherapy on the way to product-based evaluation—a WAO statement
por: Bachert, Claus, et al.
Publicado: (2015) -
Microbial Delivery Vehicles for Allergens and Allergen-Derived Peptides in Immunotherapy of Allergic Diseases
por: Zahirović, Abida, et al.
Publicado: (2018) -
Allergen immunotherapy
por: Crisafulli, Giuseppe, et al.
Publicado: (2014)